Grifols, S.A. Operating Expenses 2011-2026 | GRFS

Annual Operating Expenses Grifols, S.A.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.64 B	1.77 B	1.56 B	1.42 B	1.28 B	1.22 B	1.06 B	1.15 B	973 M	961 M	842 M	682 M	670 M	1.05 B

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
1.77 B	670 M	1.16 B

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Amarin Corporation plc AMRN	233 M	$ 14.81	-0.34 %	$ 6.04 B	Irlanda
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Legend Biotech Corporation LEGN	193 M	$ 17.8	-1.44 %	$ 18.7 B	USA
Anavex Life Sciences Corp. AVXL	51.4 M	$ 3.93	0.26 %	$ 335 M	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Aptorum Group Limited APM	20.7 M	$ 0.79	-7.27 %	$ 4.31 M	China
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.48	-0.98 %	$ 8.37 B	Australia
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Biogen BIIB	5.39 B	$ 195.63	0.06 %	$ 28.7 B	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Aptose Biosciences APTO	26.3 M	-	-45.71 %	$ 1.2 M	Canada
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
Aeglea BioTherapeutics AGLE	209 M	-	-	$ 1.01 B	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Ascendis Pharma A/S ASND	338 M	$ 216.28	-0.83 %	$ 5 B	Danmark
Bristol-Myers Squibb Company BMY	12.2 B	$ 60.51	1.12 %	$ 123 B	USA
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Arena Pharmaceuticals ARNA	427 M	-	-6.81 %	$ 3.04 B	USA
BioNTech SE BNTX	512 M	$ 106.24	0.45 %	$ 27.2 B	Germany
Aridis Pharmaceuticals ARDS	23.4 K	-	17.91 %	$ 11.1 M	USA
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
Brickell Biotech BBI	14.4 M	-	-5.38 %	$ 6.06 M	USA
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Athersys ATHX	79.8 M	-	3.77 %	$ 22.4 M	USA
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Autolus Therapeutics plc AUTL	145 M	$ 1.41	1.81 %	$ 360 M	Britain
Burford Capital Limited BUR	106 M	$ 9.33	0.32 %	$ 1.51 B	Britain
Amneal Pharmaceuticals AMRX	539 M	$ 14.8	1.13 %	$ 4.57 B	USA
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA